Pitt Street Research | Stock research

Pitt Street Research Brain Candy

Brain Candy for the intelligent ASX investor - cutting edge commentary for ASX related topics. Learn more about independent equity research for the Australien stock market on this page.

 

Cutting edge commentary from cutting edge analysts 

 

Bubble or not, Tech will always outperform through the cycle

Great piece by ABC on Tech listings in Australia, with the legend himself on camera at 3.53.


Presentations from our Australian Semiconductor Conference on 16 May 2019

 
 

We recently spoke with Rachel Williamson from Stockhead about ASX-listed Semiconductor stocks 4DS Memory, BrainChip, Weebit Nano, Sensera, Bluechiip, Revasum and Pivotal .... How new technologies and laser sharp focus can translate into very sizable market opportunities.


 
TLV.jpg

When the Start-up Nation Meets the Lucky Country

It was the kind of IPO investors wish they had more of. Splitit Payments, a monthly installment payment solution provider, raised A$12m at 20 cents per share ahead of its listing on the Australian Securities Exchange (ASX). The offer was heavily oversubscribed, and so by the end of its first day of trading on ASX on Tuesday 29 January, Splitit stock, trading under the code SPT, had made it to 38 cents. The next day it went as high as 74 cents intraday and by the end of last week it had closed at 54 cents. Welcome to what can happen when the Start-up Nation Meets the Lucky Country.

 

Compliance.jpg

Issuer-sponsored equity research in Australia -

Why ASX’s recent Guidance Note 8 amendment is a big step forward

Pitt Street Research’s bread and butter is issuer-sponsored research of companies that are publicly traded on the Australian Securities Exchange (ASX). We are big believers in the power of issuer sponsorship to enlarge the pool of quality, widely accessible research on ASX-listed companies, and thereby contribute to the overall efficiency of the Australian equity market. As such, we are very encouraged by the May 2018 publication by the ASX of an amendment to its Guidance Note 8, which expands the ASX’s ‘Continuous Disclosure’ rules to cover the way in which listed entities are allowed to use equity research that has been written about them.


podcast-header1.jpg

MiFID II is a game-changer for equities research

Stuart and Marc discuss the effects of MiFID II on the Australian listed companies landscape with Boardroom Media - 2 June 2017.

 

 
careerbuilder-original-3584.jpg

The Rise of the New Analysts

It’s been a feature of Australia’s equity market for some years now: Business is tough for the brokers and investment banks, and there are layoffs. The cuts happen across the board, but inevitably the axe falls heaviest on the research team. We estimate that the number of analysts working for participant organisations of the Australian Securities Exchange has shrunk by one-third since 2010, and for those still working in the industry, average compensation has probably dropped by a quarter.

There is, however, one interesting trend that shows signs of going the other way. We argue that analysts in Australia will in the future show up in increasing numbers at ‘independent’ firms that just do research and are not affiliated with any broker.

 

 
research_graphic.jpg

The science behind independent research: Issuer-sponsored equities research pays off

"....paid-for reports have information content for investors based on 2-day abnormal returns. After the initiation of coverage, companies experience an increase in institutional ownership, sell-side analyst following, and liquidity". 

Prof. Dr. Marcus Kirk, University of Florida, 2010